Lu Hongzhou

[Expert Profile] Lu Hongzhou, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in infectious diseases in China, working at the Third People's Hospital of Shenzhen. He has long been dedicated to clinical diagnosis, treatment, and scientific research of HIV, tropical difficult parasitic diseases, and other infectious diseases, and is an important leading figure in infectious diseases and AIDS prevention and treatment in China.

[Education & Career] Professor Lu Hongzhou graduated from a renowned medical university, worked for many years in clinical and research work on infectious diseases at the Shanghai Public Health Clinical Center, and further studied at famous international infectious disease centers. He has held academic positions including member of the Infectious Diseases Branch of the Chinese Medical Association, and has presided over grants from the National Natural Science Foundation of China and the National Key R&D Program. He has accumulated extensive experience in AIDS prevention and treatment and difficult infectious diseases, and is a senior expert in the field of infectious diseases in China.

[Areas of Expertise] Professor Lu specializes in standardized antiviral therapy and whole-course management of HIV infection, diagnosis and treatment of opportunistic infections and complications of AIDS, as well as differential diagnosis and treatment of difficult tropical parasitic diseases such as leishmaniasis and trypanosomiasis. He has extensive experience in individualized selection of AIDS antiviral drug regimens, drug resistance management, and immune reconstitution monitoring. He excels at managing difficult HIV cases of "recurrent opportunistic infections and poor antiviral response," helping numerous patients achieve viral suppression and restore immune function.

[Academic Achievements & Industry Contributions] Professor Lu has led a series of clinical studies on AIDS prevention and treatment and difficult infectious diseases, systematically evaluating the real-world effectiveness and drug resistance status of antiviral therapy in Chinese HIV-infected patients, with findings published in authoritative domestic and international journals. He has actively participated in the development of China's AIDS prevention and treatment strategies and technical guidelines, promoted the implementation of advanced concepts such as "treatment as prevention" and one-stop diagnosis and treatment, and organized the popularization of diagnostic techniques and grassroots training for tropical parasitic diseases, making important contributions to improving infectious disease and AIDS prevention and treatment levels in China and fulfilling international public health responsibilities.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of infectious disease clinical work, Professor Lu has treated tens of thousands of HIV-infected patients and various difficult infectious disease patients, helping countless AIDS patients return to normal life. He has repeatedly participated in major infectious disease outbreak treatment and public health emergency response, and has been repeatedly recognized as a national advanced worker. He is deeply trusted by patients and respected by peers alike, and is an outstanding expert in the field of infectious diseases in China.

[Honors & Reputation] Professor Lu Hongzhou serves as President of the Third People's Hospital of Shenzhen and member of the Infectious Diseases Branch of the Chinese Medical Association, among other academic positions. He has presided over national-level projects including grants from the National Natural Science Foundation of China and the National Key R&D Program, and is a senior expert in the field of infectious diseases in China. He has profound expertise in standardized HIV antiviral therapy and diagnosis and treatment of difficult tropical parasitic diseases. He has led the construction of AIDS "one-stop" diagnosis and treatment and treatment-as-prevention systems, promoted standardized application of drug resistance monitoring and immune reconstitution monitoring, and participated in the development of multiple AIDS and infectious disease diagnosis and treatment guidelines. For decades on the clinical front lines, he has helped numerous HIV-infected patients receive standardized treatment and return to normal life, and is deeply trusted by patients and respected by peers alike.